Trials / Completed
CompletedNCT01089543
A Study of E3810 for Japanese Subjects With Functional Dyspepsia (SAMURAI Study: Suppression of Acid Milieu With Rabeprazole Improving Functional Dyspepsia ) (Study E3810-J081-204)
A Multi-Center, Randomized, Double-Blind Study of E3810 for Japanese Subjects With Functional Dyspepsia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 338 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of rabeprazole compared to placebo in Japanese subjects with Functional Dyspepsia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rabeprazole | Rabeprazole 10 mg tablet taken orally once daily after breakfast for 8 weeks. |
| DRUG | Rabeprazole | Rabeprazole 20 mg tablet taken orally once daily after breakfast for 8 weeks. |
| DRUG | Rabeprazole | Rabeprazole 40 mg tablet taken orally once daily after breakfast for 8 weeks. |
| DRUG | Placebo | Rabeprazole Placebo tablet taken orally once daily after breakfast for 8 weeks. |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2010-03-18
- Last updated
- 2013-12-24
- Results posted
- 2013-11-19
Locations
46 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01089543. Inclusion in this directory is not an endorsement.